Effects of Short-Term Cigarette Smoke Exposure on Fischer 344 Rats and on Selected Lung Proteins

Toxicologic Pathology

Volumn 38, Issue 3, 2010, Pages 402-415

  Carter, Charleata A ^a   Misra, Manoj ^a  

^a LORILLARD TOBACCO COMPANY   (United States)

Author keywords

animal models; COX 2; inhalation; JNK; MMP 12; PKC; toxicity

Indexed keywords

CIGARETTE SMOKE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE ELASTASE; PROTEIN KINASE C ALPHA; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BRONCHIOLE; CELL PROLIFERATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FISCHER 344 RAT; HISTIOCYTOSIS; INFLAMMATION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; RAT; SMOKING; STRESS; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CYCLOOXYGENASE 2; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MATRIX METALLOPROTEINASE 12; PROTEIN KINASE C; PROTEINS; RATS; RATS, INBRED F344; SMOKING; TIME; TOBACCO SMOKE POLLUTION;

ANIMALIA; RATTUS;

EID: 77952471937     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310364028     Document Type: Article

References (45)

1. Bae K. M. Wang H. Jiang G. Chen M. G. Lu L. Xiao L. (2007). Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res 67, 6053–63.
2. Battershill J. M. (2005). The multiple chemicals and actions model of carcinogenesis: A possible new approach to developing prevention strategies for environmental carcinogenesis. Hum Exp Toxicol 24, 547–58.
3. Carter C. A. (2000). Protein kinase C as a drug target: Implications for drug or diet prevention and treatment of cancer. Curr Drug Targets 1, 163–83.
4. Carter C. A. Hamm J. T. (2009). Multiplexed quantitative high content screening reveals that cigarette smoke condensate induces changes in cell structure and function through alterations in cell signaling pathways in human bronchial cells. Toxicology 261, 89–102.
5. Cawston T. Carrere S. Catterall J. Duggleby R. Elliott S. Shingleton B. Rowan A. (2001). Matrix metalloproteinases and TIMPs: Properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found Symp 234, 205–18.
6. Chen C. C. Sun Y. T. Chen J. J. Chiu K. T. (2000). TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: Involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. J Immunol 165, 2719–28.
7. Churg A. Wang R. D. Tai H. Wang X. Xie C. Dai J. Shapiro S. D. Wright J. L. (2003). Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 167, 1083–89.
8. Coggins C. R. (1998). A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 26, 307–14.
9. Coggins C. R. (2001). A review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates. Toxicol Pathol 29, 550–57.
10. Dempsey E. C. Cool C. D. Littler C. M. (2007). Lung disease and PKCs. Pharmacol Res 55, 545–59.
11. Finch G. L. Nikula K. J. Chen B. T. Barr E. B. Chang I. Y. Hobbs C. H. (1995). Effect of chronic cigarette smoke exposure on lung clearance of tracer particles inhaled by rats. Fundam Appl Toxicol 24, 76–85.
12. Fujita M. Nakanishi Y. (2007). The pathogenesis of COPD: Lessons learned from in vivo animal models. Med Sci Monit 13, RA19–24.
13. Gaworski C. L. Dozier M. M. Heck J. D. Gerhart J. M. Rajendran N. David R. M. Brennecke L. H. Morrissey R. (1998). Toxicologic evaluation of flavor ingredients added to cigarette tobacco: 13-week inhalation exposures in rats. Inhal Toxicol 10, 357–81.
14. Gueders M. M. Foidart J. M. Noel A. Cataldo D. D. (2006). Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases. Eur J Pharmacol 533, 133–44.
15. Hautamaki R. D. Kobayashi D. K. Senior R. M. Shapiro S. D. (1997). Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002–4.
16. Heck J. D. Gaworski C. L. Rajendran N. Morrissey R. L. (2002). Toxicologic evaluation of humectants added to cigarette tobacco: 13-week smoke inhalation study of glycerin and propylene glycol in Fischer 344 rats. Inhal Toxicol 14, 1135–52.
17. Hodge-Bell K. C. Lee K. M. Renne R. A. Gideon K. M. Harbo S. J. McKinney W. J. (2007). Pulmonary inflammation in mice exposed to mainstream cigarette smoke. Inhal Toxicol 19, 361–76.
18. Hofmann H. S. Hansen G. Richter G. Taege C. Simm A. Silber R. E. Burdach S. (2005). Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11, 1086–92.
19. Huang C. Jacobson K. Schaller M. D. (2004). A role for JNK-paxillin signaling in cell migration. Cell Cycle 3, 4–6.
20. Jones D. A. Carlton D. P. McIntyre T. M. Zimmerman G. A. Prescott S. M. (1993). Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268, 9049–54.
21. Joos L. He J. Q. Shepherdson M. B. Connett J. E. Anthonisen N. R. Pare P. D. Sandford A. J. (2002). The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11, 569–76.
22. Karin M. Gallagher E. (2005). From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283–95.
23. Kennedy N. J. Davis R. J. (2003). Role of JNK in tumor development. Cell Cycle 2, 199–201.
24. Lahn M. Su C. Li S. Chedid M. Hanna K. R. Graff J. R. Sandusky G. E. Ma D. Niyikiza C. Sundell K. L. John W. J. Giordano T. J. Beer D. G. Paterson B. M. Su E. W. Bumol T. F. (2004). Expression levels of protein kinase C-alpha in non-small-cell lung cancer. Clin Lung Cancer 6, 184–89.
25. Lang W. Wang H. Ding L. Xiao L. (2004). Cooperation between PKC-alpha and PKC-epsilon in the regulation of JNK activation in human lung cancer cells. Cell Signal 16, 457–67.
26. Lavigne M. C. Eppihimer M. J. (2005). Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochem Biophys Res Commun 330, 194–203.
27. Liao Z. Milas L. (2004). COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer. Expert Rev Anticancer Ther 4, 543–60.
28. Manning A. M. Davis R. J. (2003). Targeting JNK for therapeutic benefit: From junk to gold? Nat Rev Drug Discov 2, 554–65.
29. Martey C. A. Pollock S. J. Turner C. K. O’Reilly K. M. Baglole C. J. Phipps R. P. Sime P. J. (2004). Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: Implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287, L981–91.
30. Meng Q. R. Gideon K. M. Harbo S. J. Renne R. A. Lee M. K. Brys A. M. Jones R. (2006). Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol 18, 555–68.
31. Nakashima S. (2002). Protein kinase C alpha (PKC alpha): Regulation and biological function. J Biochem 132, 669–75.
32. Nenan S. Boichot E. Lagente V. Bertrand C. P. (2005). Macrophage elastase (MMP-12): A pro-inflammatory mediator? Mem Inst Oswaldo Cruz 100(Suppl. 1), 167–72.
33. Ohtsuka R. Shutoh Y. Fujie H. Yamaguchi S. Haruta J. Takeda M. Harada T. Itagaki S. Doi K. (2000). Comparison of responses of respiratory system to cigarette smoke inhalation between brown norway and Fischer 344 rats. J Toxicol Pathol 13, 115–18.
34. Qu P. Du H. Wang X. Yan C. (2009). Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res 69, 7252–61.
35. Raza S. L. Nehring L. C. Shapiro S. D. Cornelius L. A. (2000). Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteinases. J Biol Chem 275, 41243–50.
36. Shipley J. M. Wesselschmidt R. L. Kobayashi D. K. Ley T. J. Shapiro S. D. (1996). Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 93, 3942–46.
37. Smith C. J. Perfetti T. A. King J. A. (2006). Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 18, 667–77.
38. Stevenson C. S. Docx C. Webster R. Battram C. Hynx D. Giddings J. Cooper P. R. Chakravarty P. Rahman I. Marwick J. A. Kirkham P. A. Charman C. Richardson D. L. Nirmala N. R. Whittaker P. Butler K. (2007). Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol 293, L1183–93.
39. Van Vunakis H. Gjika H. B. Langone J. J. (1987). Radioimmunoassay for nicotine and cotinine. IARC Sci Publ 317–30.
40. Vander Top E. A. Wyatt T. A. Gentry-Nielsen M. J. (2005). Smoke exposure exacerbates an ethanol-induced defect in mucociliary clearance of Streptococcus pneumoniae. Alcohol Clin Exp Res 29, 882–87.
41. Weston C. R. Davis R. J. (2002). The JNK signal transduction pathway. Curr Opin Genet Dev 12, 14–21.
42. Weston C. R. Davis R. J. (2007). The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142–49.
43. Williams C. S. DuBois R. N. (1996). Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 270, G393–400.
44. Witschi H. (2007). Tobacco smoke-induced lung cancer in animals—a challenge to toxicology. Int J Toxicol 26, 339–44.
45. Zhong C. Y. Zhou Y. M. Douglas G. C. Witschi H. Pinkerton K. E. (2005). MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26, 2187–95.